With extensive expertise in legal research, he navigates the intricate intersections of law and technology, specializing in computational innovations’ impact on data protection, privacy, liablity, competition, IP compliance, and more within the pharmaceutical industry. He led a biotech company to a Nasdaq listing, demonstrating prowess as Chief of Business, Chief Strategy and Innovation, and more.
Focusing on AI-driven biomedical and pharmaceutical research, he delves into complex challenges like data security, public access, and legal qualifications in Lifescience. His proactive approach transforms regulatory frameworks into strategic tools, ensuring optimal leverage for competitive advantage.
He is also Co-Founder and Head of Legal and Strategy of UK based consulting firm active on cybersecurity, copyright/data governance and protection.